{"transactions":[{"id":1425904,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP, Tech & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:06:44.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025."}],"balance_after":155000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001493152-24-033624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033624/ownership.xml","form_type":"4"}},{"id":1425903,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88095,"kind":"person","name":"Rendall David","position":1,"cik":"0001869521","reported_name":"Rendall David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:05:20.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-24-033623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033623/ownership.xml","form_type":"4"}},{"id":1425902,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:04:10.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-24-033622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033622/ownership.xml","form_type":"4"}},{"id":1425901,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:02:33.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025."}],"balance_after":155000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001493152-24-033621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033621/ownership.xml","form_type":"4"}},{"id":1425900,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:00:36.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-24-033620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033620/ownership.xml","form_type":"4"}},{"id":1425899,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88091,"kind":"person","name":"BARTLETT ROBERT F","position":1,"cik":"0001240229","reported_name":"BARTLETT ROBERT F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T21:58:36.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares are fully vested as of the date of grant."}],"balance_after":500000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-24-033619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033619/ownership.xml","form_type":"4"}},{"id":1425898,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88091,"kind":"person","name":"BARTLETT ROBERT F","position":1,"cik":"0001240229","reported_name":"BARTLETT ROBERT F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T21:58:36.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025."}],"balance_after":155000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001493152-24-033619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033619/ownership.xml","form_type":"4"}},{"id":1425897,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T21:56:02.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-24-033618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033618/ownership.xml","form_type":"4"}},{"id":1425896,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88089,"kind":"person","name":"Zehr Darin","position":1,"cik":"0002022748","reported_name":"Zehr Darin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T21:54:37.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-24-033617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033617/ownership.xml","form_type":"4"}},{"id":1816970,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88095,"kind":"person","name":"Rendall David","position":1,"cik":"0001869521","reported_name":"Rendall David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:23:02.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-044441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044441/doc4.xml","form_type":"4"}},{"id":1816969,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:20:16.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044431/doc4.xml","form_type":"4"}},{"id":1816968,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:19:13.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-044429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044429/doc4.xml","form_type":"4"}},{"id":1816967,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:17:13.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044423/doc4.xml","form_type":"4"}},{"id":1816966,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:15:37.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044419/doc4.xml","form_type":"4"}},{"id":1816965,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:14:38.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-044409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044409/doc4.xml","form_type":"4"}},{"id":1816964,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88091,"kind":"person","name":"BARTLETT ROBERT F","position":1,"cik":"0001240229","reported_name":"BARTLETT ROBERT F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:13:14.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044408/doc4.xml","form_type":"4"}},{"id":1942179,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88094,"kind":"person","name":"Blotner Bernard","position":1,"cik":"0001966742","reported_name":"Blotner Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-22T21:55:38.000Z","date":"2023-03-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.1299,"value":1299.0,"ownership":{"direct":false,"nature":"By Blotner Family Trust 3/4/98"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Blotner is a trustee of the Blotner Family Trust 3/4/98 and has voting and dispositive power with respect to these shares"}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-23-020594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123020594/doc4.xml","form_type":"4"}},{"id":1942177,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88091,"kind":"person","name":"BARTLETT ROBERT F","position":1,"cik":"0001240229","reported_name":"BARTLETT ROBERT F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-22T21:53:53.000Z","date":"2023-03-22","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.155,"value":7750.0,"ownership":{"direct":false,"nature":"Bartlett Living Trust U/A DTD 07/01/1991"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.13 to $0.1599. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bartlett is a trustee of the Bartlett Living Trust U/A DTD 07/01/1991 and has voting and dispositive power with respect to these shares."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-23-020592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123020592/doc4.xml","form_type":"4"}},{"id":2082471,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-19T23:48:30.000Z","date":"2022-12-15","kind":"purchase","acquired":true,"shares":50000,"price":0.131,"value":6550.0,"ownership":{"direct":true},"balance_after":5001843,"source":{"system":"sec-edgar","filing":"0001209191-22-062029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122062029/doc4.xml","form_type":"4"}},{"id":2145777,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:48:10.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-052321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052321/doc4.xml","form_type":"4"}},{"id":2145775,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88095,"kind":"person","name":"Rendall David","position":1,"cik":"0001869521","reported_name":"Rendall David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:39:17.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052270/doc4.xml","form_type":"4"}},{"id":2145774,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":123348,"kind":"person","name":"Taylor Kristin","position":1,"cik":"0001809801","reported_name":"Taylor Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:32:26.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052242/doc4.xml","form_type":"4"}},{"id":2145771,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:27:11.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052235/doc4.xml","form_type":"4"}},{"id":2145770,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:27:11.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052235/doc4.xml","form_type":"4"}},{"id":2145773,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:24:42.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023."}],"balance_after":200000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-22-052216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052216/doc4.xml","form_type":"4"}},{"id":2145772,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:24:42.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052216/doc4.xml","form_type":"4"}},{"id":2145769,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:16:14.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-052210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052210/doc4.xml","form_type":"4"}},{"id":2205718,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88095,"kind":"person","name":"Rendall David","position":1,"cik":"0001869521","reported_name":"Rendall David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:17:15.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":325000,"price":0.15,"value":48750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":402371,"source":{"system":"sec-edgar","filing":"0001209191-22-042562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122042562/doc4.xml","form_type":"4"}},{"id":2205717,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-19T20:15:41.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":6000000,"price":0.15,"value":900000.0,"ownership":{"direct":false,"nature":"Blessed Rock Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Plum Investments, L.P. holds a primary interest in Blessed Rock Corporation and may be deemed to have voting and investment control over the shares held by Blessed Rock Corporation.  Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":6000000,"source":{"system":"sec-edgar","filing":"0001209191-22-042561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122042561/doc4.xml","form_type":"4"}},{"id":2205716,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-19T20:15:41.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":15741666,"price":0.15,"value":2361249.9,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":29143617,"source":{"system":"sec-edgar","filing":"0001209191-22-042561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122042561/doc4.xml","form_type":"4"}},{"id":2205715,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:13:27.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":300000,"price":0.15,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001209191-22-042557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122042557/doc4.xml","form_type":"4"}},{"id":2322128,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-23T01:49:51.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":185000,"price":0.198,"value":36630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.194 to $0.1998. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":4951843,"source":{"system":"sec-edgar","filing":"0001209191-22-020677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122020677/doc4.xml","form_type":"4"}},{"id":2322127,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-23T01:49:51.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":13250,"price":0.179,"value":2371.75,"ownership":{"direct":true},"balance_after":4766843,"source":{"system":"sec-edgar","filing":"0001209191-22-020677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122020677/doc4.xml","form_type":"4"}},{"id":2322126,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-23T01:49:51.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":21227,"price":0.18,"value":3820.86,"ownership":{"direct":true},"balance_after":4753593,"source":{"system":"sec-edgar","filing":"0001209191-22-020677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122020677/doc4.xml","form_type":"4"}},{"id":2656413,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88095,"kind":"person","name":"Rendall David","position":1,"cik":"0001869521","reported_name":"Rendall David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T23:36:44.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-043164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121043164/doc4.xml","form_type":"4"}},{"id":2659478,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":123348,"kind":"person","name":"Taylor Kristin","position":1,"cik":"0001809801","reported_name":"Taylor Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:26:58.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-042596","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042596/doc4.xml","form_type":"4"}},{"id":2659476,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:25:48.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022."}],"balance_after":125000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-042595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042595/doc4.xml","form_type":"4"}},{"id":2659475,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:25:48.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-042595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042595/doc4.xml","form_type":"4"}},{"id":2659474,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:24:18.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022."}],"balance_after":200000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-21-042593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042593/doc4.xml","form_type":"4"}},{"id":2659473,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:24:18.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":150000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-042593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042593/doc4.xml","form_type":"4"}},{"id":2659472,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-23T00:24:18.000Z","date":"2021-06-16","kind":"purchase","acquired":true,"shares":35998,"price":0.431,"value":15515.138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.425 to $0.438. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4732366,"source":{"system":"sec-edgar","filing":"0001209191-21-042593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042593/doc4.xml","form_type":"4"}},{"id":2659471,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-23T00:17:15.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-042591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042591/doc4.xml","form_type":"4"}},{"id":2659470,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:14:32.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-042590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042590/doc4.xml","form_type":"4"}},{"id":2931940,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-28T22:44:18.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":851,"price":0.65,"value":553.15,"ownership":{"direct":true},"balance_after":4696368,"source":{"system":"sec-edgar","filing":"0001209191-20-065235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120065235/doc4.xml","form_type":"4"}},{"id":2931939,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-28T22:44:18.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":45299,"price":0.662,"value":29987.938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.64 to $0.68. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4695517,"source":{"system":"sec-edgar","filing":"0001209191-20-065235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120065235/doc4.xml","form_type":"4"}},{"id":2931938,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-28T22:44:18.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":7859,"price":0.68,"value":5344.12,"ownership":{"direct":true},"balance_after":4650218,"source":{"system":"sec-edgar","filing":"0001209191-20-065235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120065235/doc4.xml","form_type":"4"}},{"id":2931937,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-28T22:44:18.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":4712,"price":0.65,"value":3062.8,"ownership":{"direct":true},"balance_after":4642359,"source":{"system":"sec-edgar","filing":"0001209191-20-065235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120065235/doc4.xml","form_type":"4"}},{"id":2931936,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-28T22:44:18.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":20000,"price":0.665,"value":13300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.66 to $0.67. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4637647,"source":{"system":"sec-edgar","filing":"0001209191-20-065235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120065235/doc4.xml","form_type":"4"}},{"id":3099289,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-26T21:37:03.000Z","date":"2020-06-24","kind":"other","acquired":false,"shares":10732222,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were distributed on a pro rata basis by Plum Investments, L.P., for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":13401951,"source":{"system":"sec-edgar","filing":"0001209191-20-039138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120039138/doc4.xml","form_type":"4"}},{"id":3103461,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-23T00:58:11.000Z","date":"2020-06-22","kind":"purchase","acquired":true,"shares":13124,"price":1.72,"value":22573.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.61 to $1.82. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4617647,"source":{"system":"sec-edgar","filing":"0001209191-20-038334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120038334/doc4.xml","form_type":"4"}},{"id":3103460,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-23T00:58:11.000Z","date":"2020-06-19","kind":"purchase","acquired":true,"shares":10000,"price":1.85,"value":18500.0,"ownership":{"direct":true},"balance_after":4604523,"source":{"system":"sec-edgar","filing":"0001209191-20-038334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120038334/doc4.xml","form_type":"4"}},{"id":3103459,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-23T00:58:11.000Z","date":"2020-06-18","kind":"purchase","acquired":true,"shares":30000,"price":1.7499,"value":52497.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.62 to $1.83. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4594523,"source":{"system":"sec-edgar","filing":"0001209191-20-038334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120038334/doc4.xml","form_type":"4"}},{"id":3103458,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2020-06-22T22:45:31.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\"). 33.3% of the RSUs vest on May 1, 2021 with the remaining shares vesting in 2 equal annual installments thereafter.  Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the date of grant (May 1, 2020); (ii) sixty days after the date the Reporting Person's service with the Issuer ceases for any reason and such cessation constitutes a \"separation from service\" within the meaning of Section 409A of the Code; (iii) the date of the Reporting Person's death or (iv) the date of a Change in Control (as defined in the RSU) that constitutes a \"change in control event\" within the meaning of Section 409A of the Code."}],"balance_after":587500,"source":{"system":"sec-edgar","filing":"0001209191-20-038300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120038300/doc4.xml","form_type":"4"}},{"id":3105910,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-18T22:19:14.000Z","date":"2020-06-17","kind":"purchase","acquired":true,"shares":26876,"price":1.605,"value":43135.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.38 to $1.70. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4564523,"source":{"system":"sec-edgar","filing":"0001209191-20-037706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120037706/doc4.xml","form_type":"4"}},{"id":3105909,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-18T22:19:14.000Z","date":"2020-06-16","kind":"purchase","acquired":true,"shares":70000,"price":1.619,"value":113330.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.40 to $1.74. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4537647,"source":{"system":"sec-edgar","filing":"0001209191-20-037706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120037706/doc4.xml","form_type":"4"}},{"id":3105908,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-18T22:19:14.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":60000,"price":1.82,"value":109200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.72 to $1.88. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4467647,"source":{"system":"sec-edgar","filing":"0001209191-20-037706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120037706/doc4.xml","form_type":"4"}},{"id":3105907,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-18T22:19:14.000Z","date":"2020-06-12","kind":"purchase","acquired":true,"shares":45157,"price":1.909,"value":86204.713,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.89 to $1.94. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4407647,"source":{"system":"sec-edgar","filing":"0001209191-20-037706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120037706/doc4.xml","form_type":"4"}},{"id":3143671,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T23:05:25.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-030704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030704/doc4.xml","form_type":"4"}},{"id":3143670,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-19T23:02:31.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":125000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-030699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030699/doc4.xml","form_type":"4"}},{"id":3143669,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T22:55:22.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":200000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-030696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030696/doc4.xml","form_type":"4"}},{"id":3143668,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T22:55:22.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":150000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-030696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030696/doc4.xml","form_type":"4"}},{"id":3143667,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-19T22:52:14.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":150000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-030695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030695/doc4.xml","form_type":"4"}},{"id":3143666,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T22:06:52.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022."}],"balance_after":125000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-030646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030646/doc4.xml","form_type":"4"}},{"id":3214114,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T22:05:17.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":1551724,"price":0.29,"value":449999.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":7072264,"source":{"system":"sec-edgar","filing":"0001209191-20-018614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018614/doc4.xml","form_type":"4"}},{"id":3214117,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T22:03:49.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":2243103,"price":0.29,"value":650499.87,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":24134173,"source":{"system":"sec-edgar","filing":"0001209191-20-018612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018612/doc4.xml","form_type":"4"}},{"id":3214116,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T22:03:49.000Z","date":"2020-02-14","kind":"gift","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Tessa Melody Shin Trust Dated February 12, 2020"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares"}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001209191-20-018612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018612/doc4.xml","form_type":"4"}},{"id":3214115,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T22:03:49.000Z","date":"2020-02-14","kind":"gift","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":21891070,"source":{"system":"sec-edgar","filing":"0001209191-20-018612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018612/doc4.xml","form_type":"4"}},{"id":3214113,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T21:55:17.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":179311,"price":0.29,"value":52000.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":450000,"source":{"system":"sec-edgar","filing":"0001209191-20-018605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018605/doc4.xml","form_type":"4"}},{"id":3283078,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:54:02.000Z","date":"2019-12-31","kind":"sale","acquired":false,"shares":40000,"price":0.28,"value":11200.0,"ownership":{"direct":true},"balance_after":5520540,"source":{"system":"sec-edgar","filing":"0001209191-20-008082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120008082/doc4.xml","form_type":"4"}},{"id":3283077,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:54:02.000Z","date":"2020-12-19","kind":"sale","acquired":false,"shares":748880,"price":0.29,"value":217175.2,"ownership":{"direct":true},"balance_after":5560540,"source":{"system":"sec-edgar","filing":"0001209191-20-008082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120008082/doc4.xml","form_type":"4"}},{"id":3283076,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T23:51:47.000Z","date":"2019-12-19","kind":"purchase","acquired":true,"shares":754884,"price":0.289,"value":218161.476,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":22891070,"source":{"system":"sec-edgar","filing":"0001209191-20-008081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120008081/doc4.xml","form_type":"4"}},{"id":3287057,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T23:02:41.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The previously filed Form 4 report incorrectly stated the Code as P.  The transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors and therefore the transaction should have been reported under the Code A."}],"balance_after":6309420,"source":{"system":"sec-edgar","filing":"0001209191-20-007273","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120007273/doc4a.xml","form_type":"4/A","original_submission_date":"2019-10-03"}},{"id":3287035,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T23:00:55.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":1000000,"price":0.29,"value":290000.0,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The previously filed Form 4 report incorrectly stated the Code as P.  The transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors and therefore the transaction should have been reported under the Code A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":22136186,"source":{"system":"sec-edgar","filing":"0001209191-20-007271","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120007271/doc4a.xml","form_type":"4/A","original_submission_date":"2019-10-03"}},{"id":3297038,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-01T01:42:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in eight equal quarterly installments beginning on April 30, 2020."}],"balance_after":125000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-005911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120005911/doc4.xml","form_type":"4"}},{"id":3297037,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-01T01:39:40.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in eight equal quarterly installments beginning on April 30, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-005910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120005910/doc4.xml","form_type":"4"}},{"id":3297036,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-01T01:38:40.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in eight equal quarterly installments beginning on April 30, 2020."}],"balance_after":200000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-005909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120005909/doc4.xml","form_type":"4"}},{"id":3399286,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T22:30:22.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.29,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-052412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052412/doc4.xml","form_type":"4"}},{"id":3399285,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T22:30:22.000Z","date":"2019-10-02","kind":"purchase","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"balance_after":6309420,"source":{"system":"sec-edgar","filing":"0001209191-19-052412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052412/doc4.xml","form_type":"4"}},{"id":3399269,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T22:28:26.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest and become exercisable in four equal installments on January 1, 2020, April 1, 2020, July 1, 2020 and October 1, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.29,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-19-052410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052410/doc4.xml","form_type":"4"}},{"id":3399268,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T22:28:26.000Z","date":"2019-10-02","kind":"purchase","acquired":true,"shares":1000000,"price":0.29,"value":290000.0,"ownership":{"direct":false,"nature":"By Plum Investments, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":22136186,"source":{"system":"sec-edgar","filing":"0001209191-19-052410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052410/doc4.xml","form_type":"4"}},{"id":3399317,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T22:26:56.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":125000,"derivative":{"exercise_price":0.29,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-19-052409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052409/doc4.xml","form_type":"4"}},{"id":3446163,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T22:09:00.000Z","date":"2019-07-02","kind":"gift","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Karissa Shay Lee Trust Dated July 1, 2019"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019 and Karissa Shay Lee Trust Dated July 1, 2019 and has voting and dispositive power with respect to these shares."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001209191-19-044879","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119044879/doc5.xml","form_type":"5"}},{"id":3446162,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T22:09:00.000Z","date":"2019-07-02","kind":"gift","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019 and Karissa Shay Lee Trust Dated July 1, 2019 and has voting and dispositive power with respect to these shares."}],"balance_after":21136186,"source":{"system":"sec-edgar","filing":"0001209191-19-044879","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119044879/doc5.xml","form_type":"5"}},{"id":3446161,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T22:09:00.000Z","date":"2019-07-01","kind":"gift","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kamika Shay Lee Trust Dated July 1, 2019"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019 and Karissa Shay Lee Trust Dated July 1, 2019 and has voting and dispositive power with respect to these shares."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001209191-19-044879","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119044879/doc5.xml","form_type":"5"}},{"id":3446160,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T22:09:00.000Z","date":"2019-07-01","kind":"gift","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transactions represent a gift for no value by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":22136186,"source":{"system":"sec-edgar","filing":"0001209191-19-044879","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119044879/doc5.xml","form_type":"5"}},{"id":3479310,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T21:30:54.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":862068,"price":0.29,"value":249999.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 714,285 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 714,285 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."}],"balance_after":5447352,"source":{"system":"sec-edgar","filing":"0001209191-19-038988","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119038988/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-13"}},{"id":3479303,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T21:21:41.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":120689,"price":0.29,"value":34999.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."}],"balance_after":270689,"source":{"system":"sec-edgar","filing":"0001209191-19-038981","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119038981/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-13"}},{"id":3530348,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T22:04:44.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":714285,"price":0.35,"value":249999.75,"ownership":{"direct":true},"balance_after":5299569,"source":{"system":"sec-edgar","filing":"0001209191-19-029435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119029435/doc4.xml","form_type":"4"}},{"id":3530347,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T22:03:09.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":100000,"price":0.35,"value":35000.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001209191-19-029434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119029434/doc4.xml","form_type":"4"}},{"id":3606848,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T01:30:06.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":200000,"derivative":{"exercise_price":0.45,"expiration_date":"2029-03-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-017903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119017903/doc4.xml","form_type":"4"}},{"id":3643142,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"other","acquired":false,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643141,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on August 2014."}],"balance_after":213333,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643140,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"disposition_to_issuer","acquired":false,"shares":213333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on August 2014."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2014-08-22","expiration_date":"2019-08-22","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3643139,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":149115,"kind":"person","name":"Okuno Dale","position":1,"cik":"0001608989","reported_name":"Okuno Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T22:40:13.000Z","date":"2019-02-19","kind":"other","acquired":true,"shares":213333,"price":0.35,"value":74666.55,"ownership":{"direct":true},"balance_after":4585284,"source":{"system":"sec-edgar","filing":"0001209191-19-012192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012192/doc4.xml","form_type":"4"}},{"id":3642961,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:37:06.000Z","date":"2019-02-19","kind":"other","acquired":false,"shares":2133333,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":0,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-29","expiration_date":"2019-08-29","underlying":"Common Stock","underlying_shares":2133333},"source":{"system":"sec-edgar","filing":"0001209191-19-012187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012187/doc4.xml","form_type":"4"}},{"id":3642960,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:37:06.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":2133333,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on December 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":2133333,"derivative":{"exercise_price":0.35,"exercise_date":"2014-08-29","expiration_date":"2019-08-29","underlying":"Common Stock","underlying_shares":2133333},"source":{"system":"sec-edgar","filing":"0001209191-19-012187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012187/doc4.xml","form_type":"4"}},{"id":3642959,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-02-21T22:37:06.000Z","date":"2019-02-19","kind":"disposition_to_issuer","acquired":false,"shares":2133333,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions relate to an amendment of the exercise price of an outstanding warrant from $0.75 per share to $0.35 per share of Common Stock, contingent upon the Reporting Person immediately exercising the Warrant. As a result of this amendment, the outstanding warrant was deemed canceled and a replacement warrant was issued for the same number of shares of Common Stock, but with the reduced exercise price.  The outstanding warrant was originally issued on December 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2014-08-29","expiration_date":"2019-08-29","underlying":"Common Stock","underlying_shares":2133333},"source":{"system":"sec-edgar","filing":"0001209191-19-012187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012187/doc4.xml","form_type":"4"}},{"id":3642958,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T22:37:06.000Z","date":"2019-02-19","kind":"other","acquired":true,"shares":2133333,"price":0.35,"value":746666.55,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":23136186,"source":{"system":"sec-edgar","filing":"0001209191-19-012187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119012187/doc4.xml","form_type":"4"}},{"id":3838807,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88092,"kind":"person","name":"Lee Tom Y","position":1,"cik":"0001623609","reported_name":"Lee Tom Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-20T23:10:02.000Z","date":"2018-08-16","kind":"purchase","acquired":true,"shares":2336187,"price":0.45,"value":1051284.15,"ownership":{"direct":false,"nature":"Plum Investments, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were purchased in connection with the Issuer's private placement financing for cash and the cancellation of certain of the Reporting Person's existing indebtedness to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P."}],"balance_after":21002853,"source":{"system":"sec-edgar","filing":"0001209191-18-047688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118047688/doc4.xml","form_type":"4"}},{"id":3843800,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":164320,"kind":"person","name":"Lambert Henry R.","position":1,"cik":"0001587257","reported_name":"Lambert Henry R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-15T22:55:12.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\").  The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on December 15, 2018 and (ii) 50% of the RSUs will vest on December 15, 2019."}],"balance_after":698056,"source":{"system":"sec-edgar","filing":"0001209191-18-046889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118046889/doc4.xml","form_type":"4"}}],"next_cursor":"2018-08-15T22:55:12.000000Z,3843800"}